IASPP Polyclonal Antibody, PE-Cy5 Conjugated
Cat# bs-0284R-PE-Cy5
Size : 100ul
Brand : Bioss
IASPP Polyclonal Antibody, PE-Cy5 Conjugated
Applications
Reactivity
Predicted Reactivity
Overview | |
Catalog # | bs-0284r-pe-cy5-100ul |
Product Name | IASPP Polyclonal Antibody, PE-Cy5 Conjugated |
Applications | WB, FCM |
Reactivity | Human, Rat |
Predicted Reactivity | Mouse, Dog, Cow, Sheep, Pig, Guinea Pig |
Specifications | |
Conjugation | PE-Cy5 |
Host | Rabbit |
Source | KLH conjugated synthetic peptide derived from human IASPP |
Immunogen Range | 15-100/828 |
Clonality | Polyclonal |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein A. |
Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target | |
Gene ID | 10848 |
Swiss Prot | Q8WUF5 |
Subcellular location | Cytoplasm, Nucleus, Extracellular matrix |
Synonyms | RAI; RAI4; IASPP; NKIP1; RelA-associated inhibitor; Inhibitor of ASPP protein; Protein iASPP; NFkB-interacting protein 1; PPP1R13B-like protein; PPP1R13L; PPP1R13BL |
Background | Regulator that plays a central role in regulation of apoptosis and transcription via its interaction with NF-kappa-B and p53/TP53 proteins. Blocks transcription of HIV-1 virus by inhibiting the action of both NF-kappa-B and SP1. Also inhibits p53/TP53 function, possibly by preventing the association between p53/TP53 and ASPP1 or ASPP2, and therefore suppressing the subsequent activation of apoptosis. |
Application Dilution | |
WB | 1:300-5000 |
FCM | 1:20-100 |